Review
doi: 10.1111/j.1541-9215.2004.03320.x.
The drug-eluting stent information gap
Affiliations
- PMID: 15604835
- DOI: 10.1111/j.1541-9215.2004.03320.x
Item in Clipboard
Review
The drug-eluting stent information gap
Am Heart Hosp J.
2004 Winter.
Abstract
Drug-eluting stents are quickly replacing bare-metal stents as the arterial revascularization device of choice. Because nearly all the information we have about patient outcomes with drug-eluting stents is from trials designed for US Food and Drug Administration approval, we are missing some of the information critical to a more comprehensive understanding of how these new devices will perform at the population level.
Similar articles
-
Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?Coron Artery Dis. 2006 Dec;17(8):667-71. doi: 10.1097/MCA.0b013e3280111042. Coron Artery Dis. 2006. PMID: 17119374 Review.
-
Drug-eluting coronary stents: many meta-analyses, little benefit.Prescrire Int. 2009 Apr;18(100):70-4. Prescrire Int. 2009. PMID: 19585727
-
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.J Am Coll Cardiol. 2009 Sep 1;54(10):894-902. doi: 10.1016/j.jacc.2009.04.077. J Am Coll Cardiol. 2009. PMID: 19712798
-
Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program.Circulation. 2009 Feb 24;119(7):952-61. doi: 10.1161/CIRCULATIONAHA.108.781138. Epub 2009 Feb 9. Circulation. 2009. PMID: 19204307
-
Off-label use: an industry perspective on expanding use beyond approved indications.J Interv Cardiol. 2006 Oct;19(5):432-8. doi: 10.1111/j.1540-8183.2006.00185.x. J Interv Cardiol. 2006. PMID: 17020568 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
